Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Gilead Sciences Covid drug Remdesivir Becomes First Treatment to Win USFDA Nod

Ruchika Sharma24 Oct 2020 4:48 PM IST

New Delhi: Gilead Sciences has recently been granted approval by the U.S. Food and Drug Administration(USFDA) for antiviral drug Veklury (remdesivir)...

Covid-19 Vaccines: Johnson and Johnson, AstraZeneca resume tests in US

Ruchika Sharma24 Oct 2020 2:01 PM IST

The drugmakers said they got the go-ahead Friday from the Food and Drug Administration to restart tests in the U.S.

Maha FDA shortlists 59 pharmacists for selling Remdesivir

Ruchika Sharma24 Oct 2020 12:36 PM IST

Mumbai: The Maharashtra government on Friday came out with a list of 59 pharmacists in the state where Remdesivir, a drug used for COVID-19 treatment,...

Bharat Biotech gets DCGI nod to conduct phase 3 trial of Covaxin

Ruchika Sharma24 Oct 2020 12:26 PM IST

A subject expert committee on Covid19 at the CDSCO had recommended granting permission to the Bharat Biotech for conducting phase 3 clinical trial of...

Zydus Cadila bronchospasm drug Albuterol gets USFDA approval

Ruchika Sharma24 Oct 2020 10:30 AM IST

This medicine is used to treat and to prevent bronchospasm.

Aurobindo Pharma gets USFDA nod to generic equivalent of Ofirmev Injection

Ruchika Sharma24 Oct 2020 10:00 AM IST

Acetaminophen Injection is indicated for the treatment of mild to moderate pain in adult and pediatric patients 2 years and older.

Dr Reddys suffers cyber-attack, temporarily shuts operations across globe

Ruchika Sharma23 Oct 2020 5:45 PM IST

Bengaluru: In an alarming incident, the Hyderabad-based drugmaker Dr Reddy's Laboratories recently suffered a cyber attack. The firm has now isolated...

CDSCO says Covid vaccine Sputnik V to be tested on 100 Indian volunteers

Ruchika Sharma23 Oct 2020 1:15 PM IST

According to Russian researchers, Sputnik V is a human adenoviral vector vaccine that fights against coronavirus disease.

Granules India gets USFDA okay for Potassium Chloride ER Tablets to treat hypokalemia

Ruchika Sharma23 Oct 2020 12:00 PM IST

Hyderabad: Drugmaker, Granules India, has recently announced that the company has received marketing approval from the US Food & Drug...

CSIR-Centre developing proof of concept for Covid vaccine as part of Aurobindo Pharma pact

Ruchika Sharma23 Oct 2020 11:30 AM IST

Hyderabad: The CSIR-Centre for Cellular and Molecular Biology here has set in motion the process for development of a COVID-19 vaccine candidate...

Alembic Pharma JV Aleor Derma gets USFDA nod for Tavaborole Topical Solution

Ruchika Sharma23 Oct 2020 11:00 AM IST

Tavaborole Topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or...

Sanofi, Parkinson's Foundation join hands to advance availability of free genetic testing, counseling for Parkinson's patients

Ruchika Sharma23 Oct 2020 10:00 AM IST

Cambridge and New York and Miami: Sanofi and the Parkinson's Foundation have recently announced a new research collaboration to advance the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok